Quantbot Technologies’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Quantbot Technologies's RXRX Position: Q3 2026 in Review
Quantbot Technologies opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 7 shares worth $29. The stake represents ﹤0.01% of the portfolio and ranks #2020 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in RXRX as recently as Q4 2025.
Quantbot Technologies first reported a position in RXRX in Q4 2023 and has held it in 6 quarters since. The position peaked at $77.1K in Q4 2025. 264 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Quantbot Technologies held 7 shares of Recursion Pharmaceuticals worth $29 as of Q3 2026.
- Recursion Pharmaceuticals was a new Quantbot Technologies position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q3 2026, its #2020 holding.
- Quantbot Technologies first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
- Quantbot Technologies's Recursion Pharmaceuticals position peaked at $77.1K in Q4 2025.
- 264 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.